Age-related macular degeneration: Analysis in two ophthalmological centers in Pernambuco -Brazil;Degeneração macular relacionada à idade: Prevalência e fatores de risco em dois centros oftalmológicos de referência em Pernambuco

Arquivos Brasileiros de Oftalmologia

Volumn 68, Issue 2, 2005, Pages 229-233

  Ferreira Santos, Laura Patricía ^a,d   Diniz, José Ricardo ^b   De Souza Leão, Ana Cecília ^c   De Sena, Marília Fernandes ^c  

^a Altino Ventura Foundation FAV   (Brazil)

^b Hospital de Olhos de Pernambuco   (Brazil)

^c FAV   (Brazil)

^d Apt 201B ^*  (Brazil)

Author keywords

Aged; Aging; Alcohol intake; Macular degeneration epidemiology; Obesity; Risk factors; Smoking; Socioeconomic factors

Indexed keywords

ANTIOXIDANT;

ADULT; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; BRAZIL; CATARACT; CATARACT EXTRACTION; CONTROLLED STUDY; DIABETES MELLITUS; EYE COLOR; FEMALE; HUMAN; HYPERMETROPIA; HYPERTENSION; MALE; OBESITY; OPHTHALMOSCOPY; PREVALENCE; RACE DIFFERENCE; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SEX DIFFERENCE; SMOKING; SOCIOECONOMICS; SUN EXPOSURE;

EID: 27944439710     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492005000200014     Document Type: Article

References (19)

1. Soubrane G, Haddad WM, Coscas G. Age-related macular degeneration. Presse Med. 2002;31(27): 1282-7. Francese
2. Evans J, Wormald R. Is the incidence of registrable age-related macular degeneration increasing? Br J Ophthalmol. 1996;80(1):9-14.
3. Comment in: Br J Ophthalmol. 1996;80(l):2-3.
4. Bone RA, Landrum JT, Guerra LH, Ruiz CA. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr. 2003;133(4):992-8.
5. Erratum in: J Nutr. 2003; 133(6):1953.
6. McArty CA, Mukesh BN, Fu CL, Mitchell P, Wang JJ, Taylor HR. Risk factors for age-related maculopathy: the visual impairment project. Arch Ophthalmol. 2001;119(10):1455-62.
7. Delcourt C, Cristol JP, Tessier F, Léger CL, Descomps B, Papoz L, et al. Age-related macular degeneration and antioxidant status in the POLA study. Arch Ophthalmol. 1999;117(10):1384-90.
8. Hyman L, Schachat AP, He Q, Leske MC. Hypertension, cardiovascular disease, and age-related macular degeneration. Arch Ophthalmol. 2000;118(3):351-8.
9. Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol. 2003;121(6):785-92.
10. Cho E, Hankinson SE, Willet WC, Stampfer MJ, Spiegelman D, Speizer FE, et al. Prospective study of alcohol consumption and the risk of age-related macular degeneration. Arch Ophthalmol. 2000;118(5):681-8.
11. Pratt S. Dietary prevention of age-related macular degeneration. J Am Optom Assoc. 1999;70(l):39-47.
12. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS Report 8. Arch Ophthalmol. 2001;119(10): 1417-36.
13. Comment in: Arch Ophthalmol. 2001;119(10):1533-4.
14. Van der Hagen AM, Yolton DP, Kaminski MS, Yolton RL. Free radicals and antioxidant supplementation: a review of their roles in age-related macular degeneration. J Am Optom Assoc. 1993;64(12):871-8.
15. Oneill C, Jamison J, McCulloch D, Smith D. Age-related macular degeneration: cost-of-illness issues. Drugs Aging. 2001;18(4):233-41.
16. Koh AH, Ang CL. Age-related macular degeneration: what's new. Ann Acad Med Singapore. 2002;31(3):399-404.
17. Milton JS, Tsokos JO. Statistical methods in the biological and health sciences. In: Milton JS, Tsokos JO. Categorical data. New York: Mcgraw-Hill International Book; 1983. p.381-411.
18. Margherio RR, Margherio AR, DeSantis ME. Laser treatments with verteporfin therapy and its potential impact on retinal practices. Retina. 2000;20(4):325-30.
19. Richer S. Multicenter ophthalmic and nutritional age-related macular degeneration study-part 2: antioxidant intervention and conclusions. J Am Optom Assoc. 1996;67(l):30-49.